• Author: Mark W. Miller
Clear all

Genetic and epigenetic analysis of plasma glial fibrillary acidic protein (GFAP) levels in PTSD

Abstract: Glial fibrillary acidic protein (GFAP) is an astrocytic marker that can be assessed in blood using single molecule array technology. Recent studies suggest that …

Blood-based DNA methylation and exposure risk scores predict PTSD with high accuracy in military and civilian cohorts

Abstract: Background: Incorporating genomic data into risk prediction has become an increasingly popular approach for rapid identification of individuals most at risk for complex …

Subjective cognitive concerns, APOE ε4, PTSD symptoms, and risk for dementia among older Veterans

Abstract: Background: Posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) are associated with self-reported problems with cognition as well as risk for …

Mmpi-2-rf profiles of treatment-seeking veterans in a va pain clinic and associations with markers of physical performance

Abstract: Chronic pain is a debilitating condition for many military Veterans and is associated with posttraumatic stress disorder (PTSD). This study examined the Minnesota …

Reckless Self‐Destructive Behavior and PTSD in Veterans: The Mediating Role of New Adverse Events

Abstract: The addition of self-destructive and reckless behavior as a symptom of posttraumatic stress disorder (PTSD) in DSM-5 has stimulated renewed interest in understanding …

Group-delivered cognitive/exposure therapy for PTSD in women veterans: A randomized controlled trial

Abstract: Objective: Group delivery of posttraumatic stress disorder (PTSD) treatment has several advantages, however group research is not comparable to individual trials. This …